Ensuring reliable, consistent production in pharmaceutical water systems

Ensuring reliable, consistent production in pharmaceutical water systems

04/18/2018, 10:30 AM - 11:15 AM

Technical Conference Stage 2, Booth 1177, Exhibit Hall


Design and quality of water system equipment play a big role in optimizing pharmaceutical manufacturing - a huge, profitable and easily accessible potential. We will discuss how to ensure reliable, consistent production in pharmaceutical water systems. Pharmaceutical water systems ensure the safe, continuous and efficient operation of the pharmaceutical manufacturing facilities as well as the quality of the final end products. It is therefore critical to design pharmaceutical water systems to prevent conditions that compromise water quality by providing continuous recirculation at turbulent flows and with no dead legs. It is also important that selected equipment support good manufacturing practice (GMP) and good documentation practice (GDP) in terms of materials, surface finish, welding joints, cleanability and documentation. We will talk about system design as well as equipment design. Selecting the right equipment is paramount to securing delivery of the right quality water to the use-points at the required flow and temperature. Proper equipment design and quality can help address challenges involving potential contamination, rouge, energy use and environmental emissions as well as issues involving installation, validation and maintenance. Furthermore we will review the challenges and concerns with rouge, biofilm buildup, intensive energy consumption and finally the time consuming installation and validation process, while introducing methods to reduce these risks and share best practice.


  • David Summers


    USA Industry Director - Pharma

    Alfa Laval Inc.

    With more than two decades of international business experience in the fluid handling, process and the pharmaceutical equipment industry, David...

  • Jeff Surmon


    Industry Manager Pharma

    Alfa Laval Inc.

  • Per-Ake Ohlsson


    Manager, Global Sales Pharma, BU HFH

    Alfa Laval Shanghai Technologies Co Ltd

    Per-Åke Ohlsson is Industry Owner for Biotech & Pharmaceutical and Manager for Global Sales, Pharma fluid handling equipment at Alfa Laval. He has a...

Type of Session

  1. Type of Session

Learning Objectives

  1. Learning Objectives 1. What is rouging and why does it occur in a water system? Rouge and biofilm are well known challenges in pharmaceutical water systems. Furthermore these systems are very energy intensive. The presentation will highlight these challenges and suggest ways to overcome. 2. Reducing the risk of rouge in a water system. What is innovative is that we are looking at the greater picture here. The design recommendations and the equipment recommendations we are making are set to not only reduce risk of rouge and biofilm build-up, but at the same time reduce energy consumption and secure a safe and easy installation, validation and maintenance. 3. Reducing the risk of biofilm in a water system.


  1. Track
    Optimizing Facilities through Innovation & Technologies

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.